Vaccine News: Peru Halts Trials of China’s Sinopharm COVID-19 Vaccine After Participant Develops Guillain-Barre Syndrome

หน้าแรก / News / Vaccine News: Peru Halts Trials of China’s Sinopharm COVID-19 Vaccine After Participant Develops Guillain-Barre Syndrome


https://www.thailandmedical.news/news/vaccine-news-peru-halts-trials-of-china-s-sinopharm-covid-19--vaccine-after-participant-develops-guillain-barre-syndrome



            
                
                                            Recent News
หมอยง ชี้ วัคซีนโควิด นำมาใช้จริง ประสิทธิภาพ ต่ำกว่าการ วิจัย?
อิสราเอล เผยหมื่นคนติด “โควิด” หลังฉีดวัคซีน
Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up
SARS-CoV-2 Mutations: Study Confirms That 501Y.V2 Variant In South Africa Escapes Antibody Neutralization And Vaccines Likely Ineffective
Vaccine News: Doctors In California Call For Urgent Halt Of Moderna Vaccines After Many Fall Sick
			
	
		
	



	
		เกี่ยวกับเรา
	
	
		
	



	
		In 1993, Biogenetech started with just 10 staff, distributing diagnostic kits and nuclear medicines.

In the past 25 years, Biogenetech introduced more than 15 innovative vaccines and pharmaceuticals, contributing to the improvements in public health standards in Thailand, protecting our population from numerous infectious diseases!

	



	
	อ่านเพิ่มเติม


        

        
                    
                
                    Related Health Education
                                        
                        
                            
                                
                                    อิสราเอล เผยหมื่นคนติด “โควิด” หลังฉีดวัคซีน                                
                            
                        
                                        
                        
                            
                                
                                    Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up                                
                            
                        
                                        
                        
                            
                                
                                    SARS-CoV-2 Mutations: Study Confirms That 501Y.V2 Variant In South Africa Escapes Antibody Neutralization And Vaccines Likely Ineffective                                
                            
                        
                                        
                        
                            
                                
                                    Vaccine News: Doctors In California Call For Urgent Halt Of Moderna Vaccines After Many Fall Sick                                
                            
                        
                                        
                        
                            
                                
                                    SARS-CoV-2 Variants That Are More Transmissible Rather Than More Deadly Is Not Good News, It Only Means More Will Die!

Related Posts

Vaccine News: Peru Halts Trials of China’s Sinopharm COVID-19 Vaccine After Participant Develops Guillain-Barre Syndrome

Related Health Education